hypersensitivity and serious skin reactions associated with Intelence (etravirine)

Health Canada is warning about hypersensitivity and serious skin reactions associated with Intelence (etravirine).

These reactions are seen in patients taking combination HIV therapy that includes Intelence.

Skin reactions could potentially be fatal, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme. Hypersensitivity reactions may also include organ dysfunction such as liver failure.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote